Ignite Creation Date:
2024-05-06 @ 7:22 PM
Last Modification Date:
2024-10-26 @ 3:05 PM
Study NCT ID:
NCT05988346
Status:
COMPLETED
Last Update Posted:
2023-08-24
First Post:
2023-08-04
Brief Title:
Ghrelin and Diastolic Heart Function
Sponsor:
University of Campania Luigi Vanvitelli
Organization:
University of Campania Luigi Vanvitelli
Study Overview
Official Title:
Ghrelin Expression Could Regulate Diastolic Heart Function in Obese Patients With Diabetes
Status:
COMPLETED
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In type 2 diabetes mellitus T2DM and obese patients the adipose tissue could over-express cytokines sirtuin-1 SIRT1 and microRNAs miRs implied in the regulation of left ventricle LV diastolic function LV-DF Ghrelin could modulate these pathways Thus in the current study authors will investigate ghrelin expression in T2DM obese patients after abdominal fat excision and particularly in those with normalization of LV-DF at 1 year of follow-up
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None